Microbiotica Ltd.
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Holding
- Established
- 2016-12-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.microbiotica.com
A Phase 1b Trial to Evaluate the Safety of MB310 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
Phase 1
Recruiting
- Conditions
- Ulcerative Colitis
- Interventions
- First Posted Date
- 2024-09-03
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- Microbiotica Ltd
- Target Recruit Count
- 30
- Registration Number
- NCT06582264
- Locations
- 🇦🇹
Medizinische Universitaet Innsbruck, Innsbruck, Austria
🇦🇹Klinikum Klagenfurt am Woerthersee, Klagenfurt, Austria
🇦🇹Uniklinikum Salzburg, Salzburg, Austria
A Phase 1b Trial to Evaluate Safety of MB097 in Combination with Pembrolizumab in Melanoma Patients
Phase 1
Recruiting
- Conditions
- Melanoma
- Interventions
- First Posted Date
- 2024-08-06
- Last Posted Date
- 2025-02-07
- Lead Sponsor
- Microbiotica Ltd
- Target Recruit Count
- 40
- Registration Number
- NCT06540391
- Locations
- 🇫🇷
Centre Georges Francois Leclerc, Dijon, France
🇫🇷CHU de Lille - Hopital Claude Huriez, Lille, France
🇫🇷Centre Leon Berard, Lyon, France
© Copyright 2025. All Rights Reserved by MedPath